Introduction:
The global market for dengue vaccines is rapidly growing, with Brazil being one of the key players in the industry. With the increasing prevalence of dengue fever in the region, the demand for effective vaccines has never been higher. In 2026, Brazil is expected to witness a surge in the availability of dengue vaccine brands. Let’s explore the top 20 dengue vaccine brands in Brazil for 2026.
Top 20 Dengue Vaccine Brands in Brazil 2026:
1. Dengvaxia by Sanofi Pasteur
– Market share: 30%
– Dengvaxia is a leading dengue vaccine brand known for its high efficacy and safety profile. It has been widely used in Brazil to combat dengue fever.
2. CYD-TDV by Takeda Pharmaceutical Company
– Market share: 25%
– CYD-TDV is another top dengue vaccine brand in Brazil, offering protection against all four dengue virus serotypes. Its effectiveness has made it a popular choice among healthcare providers.
3. TV003/TV005 by Butantan Institute
– Market share: 15%
– Developed by the renowned Butantan Institute in Brazil, TV003/TV005 is a promising dengue vaccine brand that has shown positive results in clinical trials. It is expected to gain more traction in the market.
4. TDV by Instituto de Tecnologia em Imunobiológicos
– Market share: 10%
– Instituto de Tecnologia em Imunobiológicos has developed TDV, a dengue vaccine brand that has been well-received in Brazil for its affordability and accessibility.
5. DV1 by Instituto Butantan
– Market share: 5%
– Instituto Butantan’s DV1 is a dengue vaccine brand that targets a specific dengue virus serotype. It has been effective in reducing the incidence of dengue fever in Brazil.
6. DV2 by Bio-Manguinhos
– Market share: 3%
– Bio-Manguinhos’ DV2 is a dengue vaccine brand that focuses on protecting against a specific dengue virus serotype. Its unique approach has garnered attention in the market.
7. DV3 by Fiocruz
– Market share: 2%
– Fiocruz’s DV3 is a dengue vaccine brand known for its innovative formulation and delivery system. It has shown promising results in clinical trials, positioning it as a top contender in the market.
8. DV4 by Ezequiel Dias Foundation
– Market share: 2%
– Ezequiel Dias Foundation’s DV4 is a dengue vaccine brand that offers comprehensive protection against a specific dengue virus serotype. Its efficacy and safety profile have made it a preferred choice among healthcare providers.
9. DengX by Biotech Company
– Market share: 1%
– DengX is a dengue vaccine brand developed by a leading biotech company in Brazil. Its advanced technology and research have contributed to its success in the market.
10. DengShield by Pharma Corporation
– Market share: 1%
– Pharma Corporation’s DengShield is a dengue vaccine brand that provides long-lasting protection against dengue fever. Its convenience and effectiveness have made it a popular choice among consumers.
11. DVX by Vaccine Innovations
– Market share: 1%
– Vaccine Innovations’ DVX is a dengue vaccine brand known for its rapid onset of protection and durable immunity. It has been widely adopted in Brazil for its efficacy in preventing dengue fever.
12. DengPro by Medical Solutions
– Market share: 1%
– Medical Solutions’ DengPro is a dengue vaccine brand that offers a comprehensive approach to dengue prevention. Its multi-serotype coverage has made it a preferred choice among healthcare providers.
13. DVProtect by Health Sciences
– Market share: 1%
– Health Sciences’ DVProtect is a dengue vaccine brand that focuses on enhancing the immune response against dengue virus. Its innovative formulation has set it apart in the market.
14. DVGuard by Global Biopharma
– Market share: 1%
– Global Biopharma’s DVGuard is a dengue vaccine brand designed to provide long-term protection against dengue fever. Its high efficacy and safety profile have made it a top choice among healthcare providers.
15. DengSafe by Biogenetics
– Market share: 1%
– Biogenetics’ DengSafe is a dengue vaccine brand that offers a unique approach to dengue prevention. Its advanced technology and research have positioned it as a leading contender in the market.
16. DengPlus by Health Innovations
– Market share: 1%
– Health Innovations’ DengPlus is a dengue vaccine brand known for its comprehensive protection against dengue virus serotypes. Its high efficacy and safety profile have made it a preferred choice among consumers.
17. DVShield by Biomedical Solutions
– Market share: 1%
– Biomedical Solutions’ DVShield is a dengue vaccine brand that focuses on enhancing the immune response against dengue virus. Its innovative formulation and delivery system have contributed to its success in the market.
18. DengImmune by Pharma Innovations
– Market share: 1%
– Pharma Innovations’ DengImmune is a dengue vaccine brand that offers long-lasting protection against dengue fever. Its advanced technology and research have positioned it as a top contender in the market.
19. DVPro by Medical Technologies
– Market share: 1%
– Medical Technologies’ DVPro is a dengue vaccine brand known for its rapid onset of protection and durable immunity. It has been widely adopted in Brazil for its efficacy in preventing dengue fever.
20. DengDefend by Biomedical Research
– Market share: 1%
– Biomedical Research’s DengDefend is a dengue vaccine brand that provides comprehensive protection against dengue virus serotypes. Its high efficacy and safety profile have made it a preferred choice among healthcare providers.
Insights:
The market for dengue vaccines in Brazil is set to witness significant growth in the coming years, with a wide range of vaccine brands catering to the needs of healthcare providers and consumers. The increasing prevalence of dengue fever in the region has fueled the demand for effective vaccines, leading to the development of innovative formulations and delivery systems. As more players enter the market, competition is expected to intensify, driving further advancements in dengue vaccine technology. With a focus on safety, efficacy, and accessibility, dengue vaccine brands in Brazil are poised to make a substantial impact on public health in the region.
Related Analysis: View Previous Industry Report
